Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Setup of a Protocol of Molecular Diagnosis of β-Thalassemia Mutations in Tunisia using Denaturing High-Performance Liquid Chromatography (DHPLC).

Sahli CA, Ben Salem I, Jouini L, Laouini N, Dabboubi R, Hadj Fredj S, Siala H, Othmeni R, Dakhlaoui B, Fattoum S, Bibi A, Messaoud T.

J Clin Lab Anal. 2016 Sep;30(5):392-8. doi: 10.1002/jcla.21867. Epub 2016 Apr 18.

2.

Prenatal diagnosis of hemoglobinopathies in Tunisia: an 18 years of experience.

Ouali F, Siala H, Bibi A, Hadj Fredj S, Dakhlaoui B, Othmani R, Ouenniche F, Zouari F, Bouguerra B, Rezigua H, Fattoum S, Messaoud T.

Int J Lab Hematol. 2016 Jun;38(3):223-32. doi: 10.1111/ijlh.12457. Epub 2016 Mar 19.

PMID:
26993054
3.

Impaired oxygen uptake kinetics in the first high-level athlete with Hb Hope: a case study.

Touhami I, Le Gallais D, Perrey S, Bibi A, Koubaa D, Mankai R, Bartagi Z, Messaoud T, Fattoum S.

J Sports Med Phys Fitness. 2015 May;55(5):544-8. Epub 2014 Jun 20.

PMID:
24947919
4.

Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients.

Jouini L, Sahli CA, Laaouini N, Ouali F, Ben Youssef I, Dakhlaoui B, Othmeni R, Ouennich F, Hadj Fredj S, Siala H, Becher M, Toumi NE, Fattoum S, Hafsia R, Bibi A, Messaoud T.

Mol Biol Rep. 2013 Nov;40(11):6205-12. doi: 10.1007/s11033-013-2732-y. Epub 2013 Sep 25.

PMID:
24065537
5.

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia.

Sahli CA, Bibi A, Ouali F, Fredj SH, Dakhlaoui B, Othmani R, Laouini N, Jouini L, Ouenniche F, Siala H, Touhami I, Becher M, Fattoum S, Toumi Nel H, Messaoud T.

Clin Chem Lab Med. 2013 Nov;51(11):2115-24. doi: 10.1515/cclm-2013-0354.

PMID:
23800659
6.

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia.

Sahli CA, Bibi A, Ouali F, Fredj SH, Dakhlaoui B, Othmani R, Laaouini N, Jouini L, Ouenniche F, Siala H, Touhami I, Becher M, Fattoum S, El Houda Toumi N, Messaoud T.

Clin Chem Lab Med. 2013 Aug;51(8):1595-603. doi: 10.1515/cclm-2012-0842.

PMID:
23492565
7.

Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association.

Laouini N, Bibi A, Ammar H, Kazdaghli K, Ouali F, Othmani R, Amdouni S, Haloui S, Sahli CA, Jouini L, Hadj Fredj S, Siala H, Ben Romdhane N, Toumi NE, Fattoum S, Messsaoud T.

Mol Biol Rep. 2013 Feb;40(2):851-6. doi: 10.1007/s11033-012-2124-8. Epub 2012 Oct 14.

PMID:
23065279
8.

Fortuitous description of hemoglobin Hope in a high-level Tunisian athlete: molecular diagnosis and origin.

Bibi A, Touhemi I, Sahli C, Siala H, Bartagi Z, Koubaa D, Le Gallais D, Fattoum S, Messaoud T.

Ann Biol Clin (Paris). 2012 May-Jun;70(3):295-8. doi: 10.1684/abc.2012.0703.

9.

Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults.

Jouini L, Bibi A, Ouali F, Hadj Fredj S, Ouennich F, Siala H, Messaoud T, Fattoum S.

Mol Biol Rep. 2012 Apr;39(4):4619-25. doi: 10.1007/s11033-011-1253-9. Epub 2011 Sep 27.

PMID:
21947948
10.

Variants in genetic modifiers of β-thalassemia can help to predict the major or intermedia type of the disease.

Badens C, Joly P, Agouti I, Thuret I, Gonnet K, Fattoum S, Francina A, Simeoni MC, Loundou A, Pissard S.

Haematologica. 2011 Nov;96(11):1712-4. doi: 10.3324/haematol.2011.046748. Epub 2011 Jul 26.

11.

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, Drelichman G, Economou M, Fattoum S, Kattamis A, Kilinc Y, Perrotta S, Piga A, Porter JB, Griffel L, Dong V, Clark J, Aydinok Y.

Blood. 2011 Jul 28;118(4):884-93. doi: 10.1182/blood-2010-11-316646. Epub 2011 May 31. Erratum in: Blood. 2011 Nov 3;118(18):5060.

PMID:
21628399
12.

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients.

Hadj Fredj S, Fattoum S, Chabchoub A, Messaoud T.

Ann Hum Biol. 2011 Sep;38(5):561-3. doi: 10.3109/03014460.2011.557090. Epub 2011 Feb 18.

PMID:
21329479
13.

The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes.

Touhami I, Fattoum S, Bibi A, Siala H, Messaoud T, Koubaa D, Mankai R, Bartagi Z, Le Gallais D.

Eur J Appl Physiol. 2010 Apr;108(6):1075-81. doi: 10.1007/s00421-009-1314-0. Epub 2009 Dec 16.

PMID:
20013288
14.

Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.

Fredj SH, Messaoud T, Templin C, des Georges M, Fattoum S, Claustres M.

Genet Test Mol Biomarkers. 2009 Oct;13(5):577-81. doi: 10.1089/gtmb.2009.0028.

PMID:
19715466
15.

An electronic infrastructure for research and treatment of the thalassemias and other hemoglobinopathies: the Euro-mediterranean ITHANET project.

Lederer CW, Basak AN, Aydinok Y, Christou S, El-Beshlawy A, Eleftheriou A, Fattoum S, Felice AE, Fibach E, Galanello R, Gambari R, Gavrila L, Giordano PC, Grosveld F, Hassapopoulou H, Hladka E, Kanavakis E, Locatelli F, Old J, Patrinos GP, Romeo G, Taher A, Traeger-Synodinos J, Vassiliou P, Villegas A, Voskaridou E, Wajcman H, Zafeiropoulos A, Kleanthous M.

Hemoglobin. 2009;33(3):163-76. doi: 10.1080/03630260903089177.

PMID:
19657830
16.

[Clinical characteristics and outcome of cystic fibrosis: report of 16 cases].

Khemiri M, Ben Rhouma A, Bouzid S, Messaoud T, Guesmi M, Hamzaoui M, Fattoum S, Khaldi F, Barsaoui S.

Tunis Med. 2008 Jun;86(6):567-72. French.

PMID:
19216450
17.

alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S.

J Genet. 2008 Dec;87(3):229-34.

18.

Evolution of hemoglobinopathy prevention in Africa: results, problems and prospect.

Fattoum S.

Mediterr J Hematol Infect Dis. 2009 Nov 10;1(1):e2009005. doi: 10.4084/MJHID.2009.005.

19.

Point: Sickle cell trait should be considered asymptomatic and as a benign condition during physical activity.

Le Gallais D, Lonsdorfer J, Bogui P, Fattoum S.

J Appl Physiol (1985). 2007 Dec;103(6):2137-8; discussion 2141. Epub 2007 Mar 29. No abstract available.

20.
21.

[Difference albumin-transferrin interest in the iron deficiency detection in a cohort of 1288 schoolchildren in the district of Tunis].

Bibi A, Benmoussa S, Torjman A, Taboubi N, Ouali F, Cherif H, Hamzaoui L, Messaoud T, Zouari B, Fattoum S.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):565-73. French.

22.
23.

Haplotypes linked to three rare beta-thalassemia mutations, originally reported in Tunisia.

Bibi A, Messaoud T, Fattoum S.

Hemoglobin. 2006;30(2):175-81.

PMID:
16798642
24.

[Prevalence and causal factors of anemia in children in Tunisia].

El Ati J, Gaigi S, Beji C, Haddad S, Cherif S, Farhat A, Fattoum S, Ben Abdeladhim A.

Tunis Med. 2005 Sep;83(9):511-8. French.

PMID:
16383194
26.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D.

Blood. 2006 May 1;107(9):3455-62. Epub 2005 Dec 13.

PMID:
16352812
27.

[Molecular epidemiology of cystic fibrosis in Tunisia].

Messaoud T, Bel Haj Fredj S, Bibi A, Elion J, Férec C, Fattoum S.

Ann Biol Clin (Paris). 2005 Nov-Dec;63(6):627-30. French.

28.

[Cystic fibrosis of the child].

Chaabouni M, Krichen A, Ben Halima N, Aloulou H, Mahfoudh A, Hachicha M, Messoud T, Fattoum S, Triki A, Karray A.

Tunis Med. 2004 Jun;82(6):516-25. French.

PMID:
15517950
29.

A novel alpha-thalassemia nonsense mutation in codon 23 of the alpha2-globin gene (GAG-->TAG) in a Tunisian family.

Siala H, Fattoum S, Messaoud T, Ouali F, Gerard N, Krishnamoorthy R.

Hemoglobin. 2004 Aug;28(3):249-54.

PMID:
15481894
30.

Molecular basis of beta-thalassemia in the population of Tunisia.

Fattoum S, Messaoud T, Bibi A.

Hemoglobin. 2004 Aug;28(3):177-87.

PMID:
15481884
31.

HbHope/HbS and HbS/beta-thal double compound heterozygosity in a Mauritanian family: clinical and biochemical studies.

Deyde VM, Lo BB, Aw T, Fattoum S.

Ann Hematol. 2003 Jul;82(7):423-6. Epub 2003 May 23.

PMID:
12764548
32.

Hemoglobin A2' (HbA2delta') in the Mauritanian population: first results of a preliminary survey.

Deyde VM, Fattoum S, Lo BB, Plaseska D, Efremov GD.

Ann Hematol. 2002 Jul;81(7):386-8. Epub 2002 Jun 5.

PMID:
12185509
33.

Epidemiological profile of hemoglobinopathies in the Mauritanian population.

Deyde VM, Lo BB, Khalifa IO, Ly B, Ball A, Fattoum S.

Ann Hematol. 2002 Jun;81(6):320-1. Epub 2002 May 17.

PMID:
12107561
34.

[Contributions to the sociologic analysis of the impact of sickle cell disease on families from Northern Tunisia].

Hamza R, Fattoum S, Péchevis M, Cook J, Girot R.

Sante Publique. 1999 Sep;11(3):297-315. French.

PMID:
10667056
35.

The erythrocyte effects of haemoglobin O(ARAB).

Nagel RL, Krishnamoorthy R, Fattoum S, Elion J, Genard N, Romero J, Fabry ME.

Br J Haematol. 1999 Dec;107(3):516-21.

PMID:
10583251
36.

Antiphospholipid antibodies: lupus anticoagulants, anticardiolipin and antiphospholipid isotypes in patients with sickle cell disease.

Nsiri B, Ghazouani E, Gritli N, Mazigh C, Bayoudh F, Messaoud T, Fattoum S, Machghoul S.

Hematol Cell Ther. 1998 Jun;40(3):107-12.

PMID:
9698218
37.

Fibrinolytic response to venous occlusion in patients with homozygous sickle cell disease.

Nsiri B, Gritli N, Mazigh C, Ghazouani E, Fattoum S, Machghoul S.

Hematol Cell Ther. 1997 Oct;39(5):229-32.

PMID:
9395896
38.

Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.

Nsiri B, Gritli N, Bayoudh F, Messaoud T, Fattoum S, Machghoul S.

Hematol Cell Ther. 1996 Jul;38(3):279-84.

PMID:
8974793
39.

Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations.

Messaoud T, Verlingue C, Denamur E, Pascaud O, Quéré I, Fattoum S, Elion J, Férec C.

Eur J Hum Genet. 1996;4(1):20-4.

PMID:
8800923
40.

A point mutation in the protein 4.2 gene (allele 4.2 Tozeur) associated with hereditary haemolytic anaemia.

Hayette S, Morle L, Bozon M, Ghanem A, Risinger M, Korsgren C, Tanner MJ, Fattoum S, Cohen CM, Delaunay J.

Br J Haematol. 1995 Apr;89(4):762-70.

PMID:
7772513
41.

[Prenatal diagnosis of cystic fibrosis in Tunisia. Apropos of the deltaF508 mutation].

Messaoud T, Abdennebi M, Ben Ammar B, Fattoum S.

Tunis Med. 1995 Jan;73(1):43-6. French. No abstract available.

PMID:
9506121
42.

[Analysis of glycosylated A1c hemoglobin by liquid phase chromatography and immunoagglutination].

Sellami M, Labaied N, Ghanem A, Nagati K, Fattoum S.

Arch Inst Pasteur Tunis. 1995 Jan-Apr;72(1-2):3-6. French.

PMID:
9092388
43.

[Prenatal diagnosis of sickle cell anemia].

Abdennebi M, Messaoud T, Zouari F, Fattoum S.

Tunis Med. 1994 Nov;72(11):601-6. Review. French. No abstract available.

PMID:
7762086
44.

[Cystic fibrosis mutations in the Tunisian population].

Messaoud T, Abdennebi M, Elion J, Fattoum S.

Tunis Med. 1994 Aug-Sep;72(8-9):509-12. Review. French. No abstract available.

PMID:
7716818
45.

Puzzling biochemical thyroid profile in patients with multinodular goitre originating from a mild iodine deficient area in Tunisia.

el May MV, Kraiem A, Messaoud T, Fattoum S, Kammoun M, Zouaghi H, Mtimet S.

Thyroidology. 1994 Aug;6(2):61-7.

PMID:
7536452
46.

[HbC/beta-thalassemia association. Eleven cases observed in Tunisia].

Fattoum S, Guemira F, Abdennebi M, Ben Abdeladhim A.

Ann Pediatr (Paris). 1993 Jan;40(1):45-8. Review. French.

PMID:
8442646
47.

[Alpha-thalassemia in the north-east of Tunisia: three cases of hemoglobinopathy H].

Guemira F, Souilem J, Issaoui B, Messaoud T, Abbes S, Ben Abdeladhim A, Fattoum S.

Tunis Med. 1992 Oct;70(10):489-92. Review. French. No abstract available.

PMID:
1295163
48.

[HbD Iran-beta-thalassemia association in a Tunisian family].

Guemira F, Abbes S, Ducrocq R, Elion J, Fattoum S.

Ann Pediatr (Paris). 1992 Jun;39(6):369-74. French.

PMID:
1497287
49.

[Association of Hbo Arab/beta-thalassemia discovered fortuitously in 2 brothers].

Mongalgi MA, Debbabi A, Guemira F, Fattoum S.

Ann Pediatr (Paris). 1992 Apr;39(4):268-70. French.

PMID:
1616242
50.

Beta S haplotypes in various world populations.

Oner C, Dimovski AJ, Olivieri NF, Schiliro G, Codrington JF, Fattoum S, Adekile AD, Oner R, Yüregir GT, Altay C, et al.

Hum Genet. 1992 Apr;89(1):99-104.

PMID:
1577473

Supplemental Content

Loading ...
Support Center